New opportunities on the horizon as TSS expands US operations

We are expanding our US operations, with Evan Hahn to be the new VP North America. Evan brings a wealth of knowledge of the pharmaceutical clinical trial space, supporting the TSS launch of its new offering in this category.
TSS recently appointed of Evan Hahn as VP of North America to lead expansion in the strategic US life sciences market.

TSS expands US operations

Evan brings extensive expertise and over 20 years of experience applying innovative approaches to life sciences through a combination of technology and sophisticated applications of data, driving insights and efficiency in clinical development.

Before joining TSS, Evan led the growth of Medidata’s Randomization and Trial Supply software solution (RTSM) from product startup to an industry leader. At Cytel, he promoted the adoption of adaptive trial designs and drug supply forecasting. Across both organizations, he met with 100s of supply chain leaders globally, gaining broad insights into the challenges they face, receiving feedback from large pharma, startup biotechs, CROs, and regulatory agencies such as the FDA and NCI on biopharma supply challenges.

Evan explains the reason for his move to TSS: “Temperature monitoring plays a vital role in the drugs delivery cycle – and TSS is at the cutting edge of ensuring the delivery of safe and sustainable therapies to patients. I’m passionately committed to bringing innovative approaches to developing and delivering treatments and see tremendous opportunities to harness supply chain data into actionable insights – opportunities that are currently under-realized within biopharma.”

TSS’s technology-agnostic cloud platform is a ‘best in class’ solution that enables companies to transform their supply chain, by allowing for the ingestion and aggregation of data from disparate sources across that chain, providing end-to-end visibility and enabling direct to patient clinical trials while ensuring patient safety. Through advanced analytics and visualization of data we let users proactively address issues before they occur. With our Clinical Module, TSS is uniquely positioned to automate manual temperature excursion handling processes, and as such reduce burden for clinical sites and sponsor companies, while contributing to corporate sustainability goals.

For further information, please contact Matias Rodriguez, Head of Marketing. matias.rodriguez@tss.se

You may also be interested in

A map of Europe with flags marking the different countries, representing the international audience of LogiPharma Europe 2025.

Join Us at LogiPharma Europe 2026

From Temperature Data to Release Decisions—Rethinking Supply Chain Control
Read moreDownload Whitepaper
A photo of the San Antonio, Texas skyline, the location for the Global Clinical Supply Conference.

Join us at GCSC US 2022

We are glad to announce that we're participating in this year's Global Clinical Supply Conference organized by the Global Clinical Supply Group on May 1-4 in San Antonio, Texas.
Read moreDownload Whitepaper

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read moreDownload Whitepaper

You may also be interested in

A clinical trial supply chain diagram over a stack of paperwork, representing the need for automation.

Future-Proofing Clinical Trials: How Sponsors Can Up-Scale Through Automation

At this year’s Clinical Trial Supply Europe event in Barcelona, TSS took center stage to discuss one of the most pressing challenges in clinical trial supply chains—temperature monitoring. Our Key Account Manager, Anita Leposa, highlighted how automation is revolutionizing temperature integrity management, reducing manual work, and ensuring compliance for global pharmaceutical sponsors.
Read more

How To Minimise the Environmental Impact of Cloud Operations

When people think about sustainability transitions in pharmaceutical supply chains, they often focus on reducing product waste, or optimising transportation. These are both important initiatives, but there's another part of the equation that often goes unnoticed: the digital infrastructure powering modern supply chains.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.